UnitedHealth Group Incorporated $UNH Stock: Fischer Financial Services Inc. Cuts Stake

Fischer Financial Services Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 39.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 2,117 shares of the healthcare conglomerate’s stock after selling 1,395 shares during the period. Fischer Financial Services Inc.’s holdings in UnitedHealth Group were worth $777,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Watershed Private Wealth LLC increased its position in UnitedHealth Group by 10.4% in the third quarter. Watershed Private Wealth LLC now owns 638 shares of the healthcare conglomerate’s stock worth $234,000 after buying an additional 60 shares in the last quarter. Integrity Advisory Solutions LLC raised its stake in shares of UnitedHealth Group by 11.9% in the third quarter. Integrity Advisory Solutions LLC now owns 1,274 shares of the healthcare conglomerate’s stock worth $468,000 after buying an additional 135 shares during the period. First Nebraska Trust Co purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $1,497,000. Factory Mutual Insurance Co. lifted its position in shares of UnitedHealth Group by 4.4% during the 3rd quarter. Factory Mutual Insurance Co. now owns 273,616 shares of the healthcare conglomerate’s stock valued at $100,439,000 after buying an additional 11,466 shares in the last quarter. Finally, Aware Super Pty Ltd as trustee of Aware Super grew its stake in shares of UnitedHealth Group by 30.4% during the 3rd quarter. Aware Super Pty Ltd as trustee of Aware Super now owns 80,103 shares of the healthcare conglomerate’s stock valued at $29,404,000 after acquiring an additional 18,682 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings and outlook are key tailwinds. UnitedHealth’s quarterly EPS and revenue beat analysts’ estimates, and the company raised its 2026 profit outlook. Those results helped drive an approximately 11% share gain over the month through October 30. UnitedHealth Just Gained 11% in a Month: Take Profits, or Buy More?
• Positive Sentiment: Buying and value-oriented endorsements provide support. ETFs recorded net purchases of UnitedHealth shares, including $35 million in buying on October 29. BetterInvesting Magazine also named UNH its “Undervalued Stock,” though such selections are not a guarantee of future performance. UnitedHealth Group Draws ETF Buying BetterInvesting Magazine Update
• Neutral Sentiment: Optum Insight’s AI investment is a longer-term opportunity with execution risk. UnitedHealth is expanding AI tools to improve efficiency and claims processing, but rising costs mean the spending still needs to translate into profit growth. Will UNH’s Optum Insight Spending Translate Into Profit Growth?
• Negative Sentiment: Political scrutiny could weigh on sentiment. Senator Elizabeth Warren criticized the Trump administration’s approval of UnitedHealth’s $3.3 billion Amedisys acquisition, arguing the deal increases the company’s power over costs and patient care. The comments renew attention to potential regulatory and political risks. Elizabeth Warren Criticizes UnitedHealth’s Amedisys Deal

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.19% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. New Street Research set a $402.00 target price on shares of UnitedHealth Group in a research note on Friday, October 9th. Erste Group Bank lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Bank of America restated a “buy” rating and set a $450.00 price objective on shares of UnitedHealth Group in a research report on Monday, July 20th. Finally, Robert W. Baird lowered their target price on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 14th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $463.93.

UnitedHealth Group Price Performance

UNH stock opened at $403.10 on Wednesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The company’s fifty day moving average price is $390.47 and its 200-day moving average price is $363.08. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a market capitalization of $361.81 billion, a PE ratio of 23.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. The company had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. During the same period last year, the company posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.